Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement

Ivan Maillard, Valérie Schweizer, Alain Broccard, Alexandre Duscher, Lucas Liaudet, Marie Denise Schaller

Research output: Contribution to journalArticle

46 Scopus citations

Abstract

Paradoxical vocal cord movement (PVCM) is characterized by paradoxical adduction of the vocal cords during inspiration and/or expiration. Patients with severe forms of PVCM can present with acute dyspnea. In this article, we describe a patient with severe PVCM who had required tracheal intubation or tracheostomy at multiple occasions and who presented with acute hypercapnic respiratory failure. Using sedation and intralaryngeal injection of botulinum toxin type A, we could avoid more invasive intervention. Our observation shows that botulinum toxin type A should be considered in the acute care setting for severe PVCM.

Original languageEnglish (US)
Pages (from-to)874-876
Number of pages3
JournalCHEST
Volume118
Issue number3
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Keywords

  • Botulinum toxin type A
  • Dyspnea
  • Laryngospasm
  • Vocal cords

Fingerprint Dive into the research topics of 'Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement'. Together they form a unique fingerprint.

Cite this